List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 81 studies with search of: Open Studies | Prostatic Neoplasms | United States, Texas
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostatic Neoplasms;   Prostate Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
2 Recruiting Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: placebo + docetaxel/prednisone;   Drug: dasatinib + docetaxel/prednisone
3 Recruiting Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy
Condition: Prostatic Neoplasms
Interventions: Drug: Prednisone;   Drug: sunitinib;   Drug: Placebo
4 Recruiting Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: goserelin;   Drug: leuprolide acetate;   Procedure: conventional surgery
5 Recruiting Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Doxorubicin hydrochloride;   Drug: Estramustine phosphate sodium;   Drug: Ketoconazole;   Drug: Prednisone;   Drug: Vinblastine;   Radiation: Strontium chloride Sr 89;   Drug: Dexamethasone
6 Recruiting Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
Condition: Prostate Cancer
Intervention:
7 Recruiting Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: antiandrogen therapy;   Drug: docetaxel
8 Recruiting Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: flutamide;   Radiation: radiation therapy
9 Recruiting Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: zoledronic acid;   Other: placebo
10 Recruiting Finasteride in Treating Patients Undergoing Surgery for Stage II Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Finasteride;   Other: Placebo
11 Recruiting Observation or Radical Treatment in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: conventional surgery;   Procedure: quality-of-life assessment;   Radiation: brachytherapy;   Radiation: radiation therapy
12 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
13 Recruiting PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
Condition: Prostate Cancer
Intervention:
14 Recruiting A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Conditions: Cancer;   Cataract;   Low Bone Mineral Density;   Osteopenia;   Osteoporosis;   Prostate Cancer
Interventions: Biological: Denosumab;   Biological: Placebo
15 Recruiting Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer
Condition: Castrate-Resistant Prostate Cancer
Intervention: Drug: Lenalidomide (CC-5013) 10mg, 15mg, 20mg, 25mg and their respective matching placebo capsules for oral administration
16 Recruiting A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC)
Conditions: Castrate-Resistant Prostate Cancer;   Hormone Refractory Prostate Cancer
Interventions: Drug: custirsen sodium;   Drug: Isotonic, 0.9% sodium chloride
17 Recruiting Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
Condition: Castration-Resistant Prostate Cancer
Interventions: Drug: MDV3100;   Drug: Placebo
18 Recruiting A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer
Conditions: Ovarian Neoplasms;   Breast Neoplasms;   Prostatic Neoplasms
Intervention: Biological: DPX-0907 consists of 7 tumor-specific HLA-A2-restricted peptides, a universal T Helper peptide, a polynucleotide adjuvant, a liposome and Montanide ISA51 VG
19 Recruiting NY-ESO Phase I Study for Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Biological: NY-ESO-1 class I and class II peptide vaccine;   Biological: LAGE-1 class I and class II peptide vaccine
20 Recruiting Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Prednisone

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services